Since we only observed the interaction between the PARP1 and the DUX4 promoter in the FSHD cells but not the control cells, we believe that the shortening of the D4Z4 array created a genomic environment that is more accessible to PARP1. The gene discussed is DUX4; the disease is facioscapulohumeral muscular dystrophy.